Vimarsana
Biggest News Aggregation in the World

Asco Gi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asco Gi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asco Gi Today - Breaking & Trending Today

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm - Vimarsana News

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.

Considerations for Platinum-based Therapy - Vimarsana News

Considerations for Platinum-based Therapy

Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC.

Dr Dotan on the Use of Geriatric Assessments to Identify Unique Challenges in GI Cancer - Vimarsana News

Dr Dotan on the Use of Geriatric Assessments to Identify Unique Challenges in GI Cancer

Efrat Dotan, MD, discusses the use of geriatric function assessments in elderly patients with gastroesophageal cancer.

Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival - Vimarsana News

Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival

Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer.

Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC - Vimarsana News

Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC

Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.